Rosetta Genomics Announces Exercise and Closing of Underwriter's Over …

29, 2012 — /PRNewswire/ — Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the sale of an additional 825,000 ordinary shares pursuant to the exercise by the …
See all stories on this topic »